Search
for
Sort by
Research 301–330 of 1000+
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Testosterone therapy for transgender men
- Metabolic risk in PCOS: phenotype and adiposity impact
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
- Prevalence of polycystic ovary syndrome in unselected women from southern China
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Defining hirsutism in Chinese women: a cross-sectional study
- A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Hormonal contraceptives: pharmacology tailored to women's health
- No evidence for the immunocompetence handicap hypothesis in male humans
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Comparison of finasteride versus flutamide in the treatment of hirsutism